{
  "abstract": "The change in terminology from polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) is welcome,1 but it should not be treated as a neat rebranding exercise. For many patients, it is an overdue admission that the old framing was too small for the condition we are living with.",
  "authors": [
    {
      "affiliations": [
        "Cwm Taf Morgannwg University Health Board, UK"
      ],
      "name": "Araya Gautam"
    }
  ],
  "title": "PMOS: a better name should end the habit of dismissing patients",
  "uid": "35770322-ecd0-57a4-81a7-abb9b4834a25"
}
